INITIAL, CLINICAL-TRIAL OF A NEW, SPECIFIC 5-HT REUPTAKE INHIBITOR, CITALOPRAM (LU 10-171)

被引：47

作者：

GOTTLIEB, P ^{[1
]}

WANDALL, T ^{[1
]}

OVERO, KF ^{[1
]}

机构：

[1] H LUNDBECK & CO AS,RES LABS,DK-2500 COPENHAGEN,DENMARK

来源：

ACTA PSYCHIATRICA SCANDINAVICA | 1980年 / 62卷 / 03期

关键词：

D O I：

10.1111/j.1600-0447.1980.tb00611.x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：236 / 344

页数：109

共 11 条

[1] TREATMENT OF DEPRESSION WITH TRICYCLIC DRUGS - PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS [J].

ASBERG, M .

PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1976, 9 (01) :18-26

[2]

Carlsson A., 1966, MECHANISMS RELEASE B, P331

[3] PHARMACOLOGY OF A NEW PHTHALANE (LU 10-171), WITH SPECIFIC 5-HT UPTAKE INHIBITING PROPERTIES [J].

CHRISTENSEN, AV ;

FJALLAND, B ;

PEDERSEN, V ;

DANNESKIOLDSAMSOE, P ;

SVENDSEN, O .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 41 (02) :153-162

[4]

FREDRICSONOVERO K, 1978, EUR J CLIN PHARMACOL, V14, P69

[5] A RATING SCALE FOR DEPRESSION [J].

HAMILTON, M .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62

[6]

HOPFNERPETERSEN HE, 1978, NORD PSYKIAT T, V32, P463

[7]

HYTTEL J, 1977, ACTA PHARMACOL TOX, V40, P439

[8] EFFECT OF A SPECIFIC 5-HT UPTAKE INHIBITOR, CITALOPRAM (LU 10-171), ON H-3-5-HT UPTAKE IN RAT-BRAIN SYNAPTOSOMES INVITRO [J].

HYTTEL, J .

PSYCHOPHARMACOLOGY, 1978, 60 (01) :13-18

[9] NEUROCHEMICAL CHARACTERIZATION OF A NEW POTENT AND SELECTIVE SEROTONIN UPTAKE INHIBITOR - LU-10-171 [J].

HYTTEL, J .

PSYCHOPHARMACOLOGY, 1977, 51 (03) :225-233

[10]

LINGJAERDE O, 1977, NORD PSYKIAT T, V31, P384

← 1 2 →